Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 113 clinical trials
Featured trial
A Double-Blind, Randomized controlled study of Etanercept and Methotrexate in combination or as Monotherapy in subjects with Psoriatic Arthritis

A Double-Blind, Randomized controlled study of Etanercept and Methotrexate in combination or as Monotherapy in subjects with Psoriatic Arthritis

  • 451 views
  • 23 Nov, 2020
  • 1 location
Featured trial
  • 2412 views
  • 23 Nov, 2020
  • 18 locations
Featured trial
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Investigational Product in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Investigational Product in Patients With Rheumatoid Arthritis (RA) With or Without Background Disease-Modifying Anti-rheumatic Drug (DMARD) Therapy

  • 789 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Do you suffer from lower back pain?

Do you suffer from lower back pain?

  • 1562 views
  • 08 Nov, 2020
  • 1 location
A Study of Guselkumab in Participants With Active Psoriatic Arthritis (APEX)

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of PsA.

DMARD
polyarticular arthritis
peripheral arthritis
rheumatoid nodules
anti-rheumatic drugs
  • 44 views
  • 03 May, 2022
  • 161 locations
Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis (PEAPOD)

The study will aim to estimate the efficacy of apremilast compared with placebo in the treatment of juvenile psoriatic arthritis (JPsA) in pediatric participants 5 to less than 18 years of age

  • 0 views
  • 05 May, 2022
  • 18 locations
Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis. (FOREMOST)

This clinical study will test the effects of a drug called apremilast in oligoarticular psoriatic arthritis with less than 5 years of disease duration. In previous studies, apremilast has been

apremilast
  • 371 views
  • 25 Mar, 2022
  • 103 locations
A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease (STAR)

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) axial disease by assessing reduction in axial symptoms and

DMARD
anti-rheumatic drugs
biological drug
psoriasis
apremilast
  • 92 views
  • 02 May, 2022
  • 97 locations
A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis (AFFINITY)

The purpose of this study is to evaluate the efficacy of guselkumab plus golimumab combination treatment in participants with active psoriatic arthritis (PsA) and inadequate response (IR) to a

polyarticular arthritis
golimumab
adalimumab
tumour necrosis
peripheral arthritis
  • 5 views
  • 02 May, 2022
  • 27 locations
Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent (SOLSTICE)

The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) and inadequate response (IR) and/or intolerance to a prior

polyarticular arthritis
tumour necrosis
peripheral arthritis
rheumatoid nodules
psoriasis
  • 0 views
  • 03 May, 2022
  • 95 locations